MedKoo Cat#: 412391 | Name: Carpronium (free base)

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Carpronium (free base) is a biochemical

Chemical Structure

Carpronium (free base)
Carpronium (free base)
CAS#14075-13-9 (free base)

Theoretical Analysis

MedKoo Cat#: 412391

Name: Carpronium (free base)

CAS#: 14075-13-9 (free base)

Chemical Formula: C8H18NO2+

Exact Mass: 160.1332

Molecular Weight: 160.24

Elemental Analysis: C, 59.97; H, 11.32; N, 8.74; O, 19.97

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Carpronium (free base); UNII-X6UK728GLZ
IUPAC/Chemical Name
Ammonium, (3-carboxypropyl)trimethyl-, methyl ester
InChi Key
XQSLKIBWQSTAGK-UHFFFAOYSA-N
InChi Code
InChI=1S/C8H18NO2/c1-9(2,3)7-5-6-8(10)11-4/h5-7H2,1-4H3/q+1
SMILES Code
C[N+](C)(CCCC(OC)=O)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 160.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Manabe M, Tsuboi R, Itami S, Osada SI, Amoh Y, Ito T, Inui S, Ueki R, Ohyama M, Kurata S, Kono T, Saito N, Sato A, Shimomura Y, Nakamura M, Narusawa H, Yamazaki M; Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. J Dermatol. 2018 Sep;45(9):1031-1043. doi: 10.1111/1346-8138.14470. Epub 2018 Jun 4. PMID: 29863806. 2: Minamiyama M, Minato T, Yamamoto A, Kaihatsu T, Tsunoda K. Effects of carpronium chloride on the microvascular blood flow in rat mesentery using intravital videomicroscopy. Clin Hemorheol Microcirc. 2006;34(1-2):125-9. PMID: 16543627. 3: Ohya K, Sano M. Analysis of drugs by pyrolysis. I. Selected ion monitoring combined with a pyrolysis method for the determination of carpronium chloride in biological samples. Biomed Mass Spectrom. 1977 Aug;4(4):241-7. doi: 10.1002/bms.1200040410. PMID: 912024. 4: Sano M, Ohya K, Ito R. Identification of carpronium chloride and its metabolite in human urine by field desorption mass spectrometry using deuterium labelling. Biomed Mass Spectrom. 1979 Nov;6(11):467-71. doi: 10.1002/bms.1200061102. PMID: 534684. 5: Sano M, Ohya K, Shintani S. Analysis of drugs by pyrolysis. II--An improved method for the determination of carpronium chloride in plasma by selected ion monitoring. Biomed Mass Spectrom. 1980 Jan;7(1):1-6. doi: 10.1002/bms.1200070102. PMID: 7397317. 6: Ishida H, Mitsui K, Nukaya H, Matsumoto K, Tsuji K. Study of active substances involved in skin dysfunction induced by crowding stress. I. Effect of crowding and isolation on some physiological variables, skin function and skin blood perfusion in hairless mice. Biol Pharm Bull. 2003 Feb;26(2):170-81. doi: 10.1248/bpb.26.170. PMID: 12576676. 7: Shiraishi T. Effects of the non-amphetaminergic anorexiant, mazindol, on neuronal activity and hypothalamic control of gastric acid secretion in rats. Int J Obes. 1985;9(4):285-97. PMID: 3905642. 8: Morita K, Nakamura M, Nagamachi M, Kishi T, Miyachi Y. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies. J Dermatol. 2002 Oct;29(10):661-4. doi: 10.1111/j.1346-8138.2002.tb00199.x. PMID: 12433000. 9: Shiraishi T. [Mazindol effects on the salivary and gastric acid secretory mechanisms]. Nihon Yakurigaku Zasshi. 1984 Feb;83(2):159-72. Japanese. PMID: 6745806. 10: Uchida T, Yamashita S. Purification and properties of choline kinase from rat brain. Biochim Biophys Acta. 1990 Apr 17;1043(3):281-8. doi: 10.1016/0005-2760(90)90028-v. PMID: 2157491.